Evidence map

TrialDiabetes & metabolism2020

Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).

M S Capehorn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

187 papers cite itlatest 60 shown

2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 31539622